FDAnews Device Daily Bulletin

NIR Diagnostics, a developer of near-infrared diagnostic instruments, has announced the issuance of a U.S. patent titled, "Sample Tab," a patent under license by the company.

The "Sample Tab" patent provides protection for the patient sample interface of the HemoNIR device. HemoNIR is a portable, reagentless co-oximetry device that uses a droplet of whole blood to monitor nonfunctional hemoglobin. The device will reduce the pain of blood testing and provide immediate and accurate blood-test results for carbon monoxide poisoning and methemoglobinemia caused by smoke inhalation and drug use, respectively.

NIR Diagnostics has also licensed a U.S. patent titled, "Method for Calibrating Spectroscopic Apparatus," related to the HemoNIR device, and has two additional patent applications related to HemoNIR that are currently under review by the patent office.